Welcome to singular mAb experience
Rat Monoclonal Antibodies
Guinea pig Monoclonal Antibodies
SYnAbs Singular Antibodies
Immunoassays provider
MYstick, mouse isotyping kit
Residual protein A
Immunoaffinity columns
Primary monoclonal antibodies
Anti-His tag antibodies
Anti-steroids antibodies
anti-DNP irrelevant antibodies
Isotype control antibodies
Anti-toxins antibodies
Anti-HRP, FITC, Biotin & Quenchers antibodies
Anti-pathogens antibodies
Anti-cytokines & anti-hormones antibodies
Anti-proteins antibodies
Anti-chemical compounds antibodies
Secondary monoclonal antibodies
Anti-human antibodies
Anti-camelid antibodies (anti-VHH)
Anti-mouse antibodies
Anti-rat antibodies
Anti-guinea pig antibodies
Anti-species antibodies
Anti-rabbit antibodies
Custom monoclonal antibody development
Aflatoxin antibodies
Carbohydrate-specific antibodies
Neo-epitopes antibodies
Epigenetic modifications antibodies
Therapeutic antibodies
Peptide biomarkers antibodies
Infectious diseases antibodies
Lipid antibodies
About SynAbs
SynAbs recent news
Distribution agreement
Congress
Organic growth
Technical breakthrough
Distributors of SynAbs mAbs catalogue
Partners for one-stop-shop mAb solution
Contact SynAbs
Glossary and Frequently Asked Questions
Innovative
Rat & Guinea Pig
Monoclonals Antibodies
Against Small Molecules
About SynAbs
SynAbs recent news
Posts tagged with "therapeutics"
Show all posts
Technical breakthrough
· 03. August 2016
Guinea pig monoclonal antibodies : a new promising tool for R&D, IVD and therapeutics
SynAbs is only company in the world to have develop guinea pig monoclonal antibodies and myeloma cell line
Read more...
Scroll to top
